7th International Symposium on Filoviruses - Ebola: West Africa and Recent Developments

Страна: США

Город: Washington

Тезисы до: 29.01.2015

Даты: 25.03.15 — 28.03.15

Область наук: Биологические;

Е-мейл Оргкомитета: filovirus@target-conferences.com

Организаторы: Target Conferences Ltd.

 

Participants are invited to submit abstracts for both oral & poster presentation.

A Reduced registration fee will be made available to the 10 best student abstracts. 

All abstracts must be submitted online. Abstracts sent by e-mail will not be reviewed.

While submitting an abstract, please ensure all authors are included with their their full name and surname and their affiliations. Submission of an abstract acknowledges your acceptance for the abstract to be published in the official meeting publication. All abstracts accepted and published must have a registered presenting author. 

 Confirmed Speakers

Christopher Basler, MSSM, USA
Potential therapeutics and novel properties of the 2014 Ebola virus identified with an optimized assay for the Ebola virus RNA synthesis machinery

 

Luke Bawo, MHSW, Liberia

 

Stephan Becker, University of Marburg, Germany

 

Yogesh Chander, Lucigen, USA

EMDx: A rapid, field appropriate molecular diagnostic test for Ebola virus

 

James E. Crowe, Vanderbilt University, USA

Human neutralizing antibody responses to filoviruses

 

John Dye, USAMRIID, USA

Liberia pilot study of convalescent plasma from survivors as a therapeutic option in the 2014 West Africa ebolavirus outbreak

John Eldridge, Profectus, USA

Darryl Falzarano, VIDO-InterVac, Canada

Anthony Fauci, NIAID, USA

The Response to the Ebola Outbreak: A View from the NIH

Heinz Feldmann, RML, USA

Robert Garry, Tulane University, USA

Perspectives on the Ebola outbreak in the Lassa fever zone from Kenema Government Hospital
 
Thomas W. Geisbert, University of Texas Medical Branch, USA

Stephan Guenther, Bernhard Nocht Institute, Germany

 Fred Hayden, UVA, USA

Ali S. Khan, University of Nebraska, USA

Healthcare preparedness in the US

Gary Kobinger, NML, Canada

Replication and fitness of the Makona virus in humans and NHPs

 Colleen Kraft, Emory University, USA

Treating Patients with Ebola Virus Infection in the U.S.: Lessons Learned

 Michael G. Kurilla, NIH, USA

 Ian MacLachlan, Tekmira, Canada

Brian Martin, Newlink Genetics, USA

Advanced development of the rVSV∆G-ZEBOV vaccine

 Jean Vivien Mombouli, Brazzaville, Republic of Congo

 Jean Jacques Muyembe-Tamfum, Kinshasa, Democratic Republic of the Congo

 Stuart Nichol, CDC, USA

 Robin Robinson, USA

 Nancy Sullivan, NIH, USA

Armand Sprecher, MSF, Belgium

 Jonathan S. Towner, CDC, USA

Viktor Volchkov, Insern, France

 Travis Warren, USAMRIID, USA

Larry Zeitlin, Mapp Bio, USA

The Development of ZMappTM

Веб-сайт конференции: http://www.filovirus2015.com/

Конференции по теме - с близкими дедлайнами: